After delivering strong sales growth last year and with more expansion in mind, CDMO giant Wuxi Biologics is breaking ground ...

After two years of quietly shifting its medical affairs and commercial strategy units under one roof, Astellas is entering a ...

Rechon Life Sciences, a Sweden-based pharma contract manufacturer, was hit with a warning letter from the FDA following an ...

Argenx has signed on as an early partner to a newly launched initiative from media companies NBCUniversal Local and Digital ...

Each year, the American Society of Clinical Oncology annual meeting brings together the biggest names and brightest minds in ...

In its continued bid to waylay the launch of MSN Pharmaceuticals’ proposed Entresto generic, Novartis has told a federal ...

Days after FDA Commissioner Marty Makary said that the agency planned to review the safety of abortion pill mifepristone, ...

Researchers have zeroed in on yet another possible ocular concern for diabetes patients who take popular GLP-1 therapies in a ...

The PD-(L)1xVEGF field had a roller coaster week marked by an imperfect readout and a potentially $11 billion deal. | The PD- ...

Drugmakers and contract manufacturers are responding to the booming demand for antibody-drug conjugates, with multiple ...

Orca Bio is preparing to make a splash in the cell therapy market. | Orca Bio is preparing to make a splash in the cell ...

The Council is now set to begin negotiations with the European Parliament on the package, after which the rules would be ...